Clinical Trials Logo

Filter by:
NCT ID: NCT02344173 Completed - Atrial Fibrillation Clinical Trials

ABLATOR Ablation Observational Registry

ABLATOR
Start date: November 2014
Phase:
Study type: Observational [Patient Registry]

The purpose of this registry is to assess the performance and clinical effectiveness of a combination of SJM mapping and ablation products in the treatment of subjects with atrial fibrillation (AF).

NCT ID: NCT02344043 Completed - Sepsis Clinical Trials

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness

CONFOCAL
Start date: March 2014
Phase: N/A
Study type: Observational

Purpose of the Study Critical illness requiring life support affects over 150 000 people in Ontario every year. With aggressive support, the number of people who die from critical illness is decreasing. However, people who survive often have neurological problems. These neurological problems often include difficulties with memory, concentration, and attention. These problems are associated with poor quality of life among survivors of critical illness. The aim of this study is to identify the factors that contribute to these neurological deficits. Specifically, the investigators are testing whether changes in oxygen delivery to the brain during critical illness are related to both short- and long-term neurological complications. Procedures involved in the Research When patients are diagnosed with a critical illness such as shock or respiratory failure, they are treated with intravenous fluids, medications to raise their blood pressure, and can be placed on a ventilator to assist with their breathing. They are observed in an intensive care unit (ICU). This research protocol does NOT interfere with the normal treatment of patients with critical illness. The procedure involved in this research protocol requires the placement of two stickers to either side of the patient's forehead, and information about oxygen delivery to the brain will be recorded. When the patient has recovered from the critical illness, they will be asked to perform several neurological tests. Some of these tests will be done with a pencil and paper, while others will use a robotic device to test arm movements, reaction time, and concentration. Potential Harms, Risks or Discomforts: This research study involves the placement of a sticker sensor to either side of the forehead. Rarely, patients may develop a rash to these electrodes. The investigators monitor patients very carefully for rashes, and if a rash is to occur, the sticker sensor will be removed. With regards to the neurological testing, rarely patients can have some mild muscle stiffness after moving their arms in the robot. The investigators do not expect any other further harms, risks, or discomforts.

NCT ID: NCT02343718 Completed - Refractory Lymphoma Clinical Trials

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Start date: June 24, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the best dose of vinblastine that can be given with a new drug, temsirolimus.

NCT ID: NCT02343406 Completed - Glioblastoma Clinical Trials

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

INTELLANCE-2
Start date: February 17, 2015
Phase: Phase 2
Study type: Interventional

This study was conducted to evaluate the efficacy and safety of depatuxizumab mafodotin (ABT-414) alone or with temozolomide versus temozolomide or lomustine alone in adult participants with recurrent glioblastoma. The study also included a substudy to evaluate safety, tolerability and pharmacokinetics of ABT-414 in a pediatric population.

NCT ID: NCT02343354 Completed - Clinical trials for Gestational Diabetes Mellitus With Baby Delivered

The MoMMii Study. Diabetes Prevention Intervention on Families With Past Gestational Diabetes

MoMMii
Start date: November 2014
Phase: N/A
Study type: Interventional

Women with gestational diabetes (GDM) have increased risk of developing type 2 diabetes; their children show more insulin resistance and diabetes compared to offspring of mother without diabetes in pregnancy. An increased diabetes risk is also observed among partner of adult with prediabetes/type 2 diabetes. The investigators have pilot-tested a program for diabetes risk reduction among women within 5 years of a GDM pregnancy (MoMM program). The investigators are now enhancing the program to engage directly the partner (MoMMii program). In MoMMii, 66 couples with a history GDM in the mother will participate in a multimodal diabetes prevention program that includes healthy meal preparation training, discussion of eating and physical activity behaviours and developing home environments that facilitate healthy habits, pedometer-based step count monitoring, and participation in family-based activities (frisbee, soccer) as well as individual exercise (e.g., use of exercise equipment, floor resistance exercises). Participants will be encouraged to communicate between sessions with study personnel and with one another to create a between family support network. All mothers and fathers will participate in five sessions over six months. The investigators will examine changes in health-related behaviours, blood pressure, glucose levels, and insulin sensitivity/resistance in both mothers and fathers.

NCT ID: NCT02343172 Completed - Liposarcoma Clinical Trials

Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma

Start date: March 13, 2015
Phase: Phase 1
Study type: Interventional

To determine the MTD/RP2D of the HDM201 and LEE011 combination and evaluate whether the combination is safe and has beneficial effects in patients with liposarcoma.

NCT ID: NCT02343055 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

COPE With COPD Trial

Start date: October 2011
Phase: N/A
Study type: Interventional

The overall objective of this study is to evaluate a collaborative self-management intervention in patients with moderate to severe COPD in a primary care population. To achieve this objective the investigators developed a diagnostic and treatment pathway for the management of COPD in primary care that is based on national guidelines and focused on patient self-management.

NCT ID: NCT02342340 Completed - Healthy Clinical Trials

Bioavailability of Compounds From Different Bean Varieties in Healthy Individuals.

BBB-2014
Start date: January 2015
Phase: N/A
Study type: Interventional

This is a single site, blinded, randomized, controlled study designed to examine phytochemical absorption, metabolism and excretion, as well as vascular health and satiety, after ingestion of 4 different bean varieties (pinto, navy, red kidney, black). Eligible participants will attend 6 in-person clinic visits for comparative testing of the 4 bean varieties versus lentils and rice.

NCT ID: NCT02342301 Completed - Sedentary Lifestyle Clinical Trials

Cardiometabolic Response to Sit-stand Workstations.

Start date: September 2014
Phase: N/A
Study type: Interventional

We aim to determine if changing a person's workstation from a traditional seated desk to a height adjustable "standing desk" for a period of approximately 3 months is associated with alterations in traditional measures of cardiometabolic risk.

NCT ID: NCT02342249 Completed - Influenza A Clinical Trials

Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects

Start date: December 11, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the antiviral effect, as measured by viral titer in nasal secretions in adults with acute uncomplicated seasonal influenza A following administration of VX-787.